Candida Albicans
Morphology |
Fungus belonging to the Candiaceae family. Polymorphic fungus as it can occur as yeast
or pseudohyphal forms.
|
---|---|
Disease |
Opportunistic commensal pathogen causing candidiasis such as thrush (oral), vaginal infections, superficial infection of mucous membranes, eye infections, macerated skin infections. |
Zoonosis |
None. |
Host Range |
Humans.
|
---|---|
Modes of Transmission |
Most infections result from the patient’s own flora, rather than from cross infection.
|
Signs and Symptoms |
Most frequent clinical form is thrush/oral candidiasis and is characterized by white
patches.
|
Infectious Dose | unknown |
Incubation Period |
unknown
|
Prophylaxis | None available. |
---|---|
Vaccines | None available. |
Treatment |
Amphotericin B, nystatin, flucytosine, the azoles, echinocandins
|
Surveillance | Monitor for symptoms. |
MSU Requirements | Report any exposures |
Laboratory Acquired Infections (LAIs) | Low risk of infection. A medical student has been reported to have developed a rash
and folliculitis 2 days after she spilled a heavy suspension of C. albicans on her
leg while conducting a laboratory experiment.
|
---|---|
Sources |
Epithelial scrapings or exudates from lesions, sputum, bronchoalveolar lavage, and
blood. Cultures, frozen stocks, other samples described in IBC protocol.
|
Canadian MSDS: | http://www.phac-aspc.gc.ca/lab-bio/res/psds-ftss/index-eng.php |
---|---|
BMBL
|
https://www.cdc.gov/labs/bmbl/?CDC_AAref_Val=https://www.cdc.gov/labs/BMBL.html |
CDC
|
|
NIH Guidelines
|
Risk Group 2
|
Agents that are associated with human disease which is rarely serious and for which preventive or therapeutic interventions are often available. |
---|---|
BSL2
|
For all procedures involving suspected or known infectious specimen or cultures.
|
ABSL2
|
For all procedures utilizing infected animals.
|
Small
|
Notify others working in the lab. Remove PPE and don new PPE. Cover area of the spill
with absorbent material and add fresh 1:10 bleach:water. Allow 20 munutes (or as directed)
of contact time. After 20 minutes, cleanup and dispose of materials.
|
---|---|
Large
|
|
Mucous membrane
|
Flush eyes, mouth, or nose for 5 minutes at eyewash station.
|
---|---|
Other Exposures
|
Wash area with soap and water for 5 minutes.
|
Reporting |
Immediately report incident to supervisor, complete a First Report of Injury form, and submit to Safety and Risk Management.
|
Medical Follow-up
|
During business hours: Bridger Occupational Health 3406 Laramie Drive. Weekdays 8am -6pm. Weekends 9am-5pm
After business hours: Bozeman Deaconess Hospital Emergency Room 915 Highland Blvd Bozeman, MT |
Disinfection |
Susceptible to 1:10 bleach:water, 70 % ethanol, and 4 % potassium iodide, accelerated
hydrogen peroxide
|
---|---|
Inactivation |
Inactivated moist heat (1 hour at 121oC).
|
Survival Outside Host |
Can survive on inanimate surfaces for 24 hours to 120 days, and on palms for about
45 minutes.
|
Minimum PPE Requirements
|
Lab coat, disposable gloves, safety glasses, closed toed shoes, long pants
|
---|---|
Additional Precautions
|
Additioanl PPE may be required depending on lab specific SOPs and IBC Protocol. |